136 related articles for article (PubMed ID: 14571736)
1. Effects of octreotide and propranolol on colonic mucosa in rats with portal hypertensive colopathy.
Aydede H; Sakarya A; Erhan Y; Kara E; Ilkgul O; Ozdemir N
Hepatogastroenterology; 2003; 50(53):1352-5. PubMed ID: 14571736
[TBL] [Abstract][Full Text] [Related]
2. Effects of ocreotide on intestinal mucosa in rats with portal hypertensive enteropathy.
Aydede H; Seda Vatansever H; Erhan Y; Ilkgül O
Acta Histochem; 2009; 111(1):74-82. PubMed ID: 18554688
[TBL] [Abstract][Full Text] [Related]
3. [Effects of sandostatin on gastric mucosal perfusion in rats with portal hypertensive gastropathy].
Le Q; Zhang X; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):21-3. PubMed ID: 10712778
[TBL] [Abstract][Full Text] [Related]
4. Portal hypertensive colopathy: histologic appearance of the colonic mucosa.
Ponce González JF; Dominguez Adame Lanuza E; Martin Zurita I; Morales Méndez S
Hepatogastroenterology; 1998; 45(19):40-3. PubMed ID: 9496484
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term administration of octreotide in portal vein-stenosed rats.
Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
7. Effects of octreotide and a-tocopherol on bacterial translocation in experimental intestinal obstruction: a microbiological, light and electronmicroscopical study.
Reis E; Kama NA; Coskun T; Korkusuz P; Ors U; Aksoy M; Kulaçoglu S
Hepatogastroenterology; 1997; 44(15):656-63. PubMed ID: 9222666
[TBL] [Abstract][Full Text] [Related]
8. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
[TBL] [Abstract][Full Text] [Related]
9. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
[TBL] [Abstract][Full Text] [Related]
10. Portal hypertensive colopathy in patients with liver cirrhosis.
Ito K; Shiraki K; Sakai T; Yoshimura H; Nakano T
World J Gastroenterol; 2005 May; 11(20):3127-30. PubMed ID: 15918202
[TBL] [Abstract][Full Text] [Related]
11. [The effects of octreotide on portal hemodynamics in patients with liver cirrhosis].
Zhu Q; Jiang XH; Yi F; Jiang Y; Sun YW; Yuan YZ; Wu YL
Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):16-8. PubMed ID: 14990014
[TBL] [Abstract][Full Text] [Related]
12. The effects of the Pringle maneuver on the pancreas: can octreotide be protective?
Unalp OV; Aydin U; Yazici P; Nart D; Yenisey C; Kavak T; Zeytunlu M; Coker A
JOP; 2009 May; 10(3):284-91. PubMed ID: 19454821
[TBL] [Abstract][Full Text] [Related]
13. The portal hypertensive gastric mucosa: histologic, ultrastructural, and functional analysis after aspirin-induced damage.
Sarfeh IJ; Tarnawski A; Hajduczek A; Stachura J; Bui HX; Krause WJ
Surgery; 1988 Jul; 104(1):79-85. PubMed ID: 3388181
[TBL] [Abstract][Full Text] [Related]
14. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.
Vorobioff JD; Ferretti SE; Zangroniz P; Gamen M; Picabea E; Bessone FO; Reggiardo V; Diez AR; Tanno M; Cuesta C; Tanno HE
Am J Gastroenterol; 2007 Oct; 102(10):2206-13. PubMed ID: 17608776
[TBL] [Abstract][Full Text] [Related]
15. Vascular alterations of the colonic mucosa in schistosomiasis and portal colopathy.
Geboes K; el-Deeb G; el-Haddad S; Amer G; el-Zayadi AR
Hepatogastroenterology; 1995; 42(4):343-7. PubMed ID: 8586365
[TBL] [Abstract][Full Text] [Related]
16. The gastric mucosa in portal hypertension: effects of topical bile acid.
Sarfeh IJ; Tarnawski A; Maeda R; Raymont K; Mason GR; Ivey KJ
Scand J Gastroenterol Suppl; 1984; 92():189-94. PubMed ID: 6588511
[TBL] [Abstract][Full Text] [Related]
17. Blood digestion-induced splanchnic hyperemia and portal blood flow in portal hypertensive rats and the role of octreotide.
Kotzampassi K; Eleftheriadis E
J Gastroenterol; 1998 Oct; 33(5):678-83. PubMed ID: 9773932
[TBL] [Abstract][Full Text] [Related]
18. Expression of endothelin receptors in the gastric mucosa of portal hypertensive rats.
Kai S; Bandoh T; Ohta M; Matsumoto T; Tominaga M; Kitano S
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):242-50. PubMed ID: 16460481
[TBL] [Abstract][Full Text] [Related]
19. The effect of prostacyclin on the gastric mucosa in portal-hypertensive rats.
Kishihara F; Hashizume M; Ohta M; Kawanaka H; Tomikawa M; Higashi H; Tanoue K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):279-84. PubMed ID: 11941975
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of 8-day octreotide and prazosin administration in portal hypertensive rats.
Lin HC; Wu HL; Huang YT; Hou MC; Lee SD; Hong CY
Eur J Clin Invest; 1998 Aug; 28(8):622-8. PubMed ID: 9767356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
